NVS
Price
$97.52
Change
-$0.35 (-0.36%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
197.93B
14 days until earnings call
OGN
Price
$15.76
Change
-$0.42 (-2.60%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
4.73B
27 days until earnings call
Ad is loading...

NVS vs OGN

Header iconNVS vs OGN Comparison
Open Charts NVS vs OGNBanner chart's image
Novartis AG
Price$97.52
Change-$0.35 (-0.36%)
Volume$10.83K
Capitalization197.93B
Organon & Co
Price$15.76
Change-$0.42 (-2.60%)
Volume$30.15K
Capitalization4.73B
NVS vs OGN Comparison Chart
Loading...
NVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NVS vs. OGN commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVS is a Hold and OGN is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (NVS: $97.86 vs. OGN: $16.18)
Brand notoriety: NVS and OGN are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: NVS: 252% vs. OGN: 60%
Market capitalization -- NVS: $197.93B vs. OGN: $4.73B
NVS [@Pharmaceuticals: Major] is valued at $197.93B. OGN’s [@Pharmaceuticals: Major] market capitalization is $4.73B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVS’s FA Score shows that 3 FA rating(s) are green whileOGN’s FA Score has 2 green FA rating(s).

  • NVS’s FA Score: 3 green, 2 red.
  • OGN’s FA Score: 2 green, 3 red.
According to our system of comparison, NVS is a better buy in the long-term than OGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVS’s TA Score shows that 4 TA indicator(s) are bullish while OGN’s TA Score has 4 bullish TA indicator(s).

  • NVS’s TA Score: 4 bullish, 5 bearish.
  • OGN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NVS is a better buy in the short-term than OGN.

Price Growth

NVS (@Pharmaceuticals: Major) experienced а -2.35% price change this week, while OGN (@Pharmaceuticals: Major) price change was +1.13% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.33%. For the same industry, the average monthly price growth was -0.62%, and the average quarterly price growth was -7.03%.

Reported Earning Dates

NVS is expected to report earnings on Apr 29, 2025.

OGN is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-0.33% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVS($198B) has a higher market cap than OGN($4.73B). NVS has higher P/E ratio than OGN: NVS (23.38) vs OGN (4.64). OGN YTD gains are higher at: 8.445 vs. NVS (0.565). NVS has higher annual earnings (EBITDA): 18.3B vs. OGN (1.44B). NVS has more cash in the bank: 14B vs. OGN (693M). OGN has less debt than NVS: OGN (8.76B) vs NVS (26.3B). NVS has higher revenues than OGN: NVS (46.7B) vs OGN (6.26B).
NVSOGNNVS / OGN
Capitalization198B4.73B4,187%
EBITDA18.3B1.44B1,274%
Gain YTD0.5658.4457%
P/E Ratio23.384.64504%
Revenue46.7B6.26B746%
Total Cash14B693M2,020%
Total Debt26.3B8.76B300%
FUNDAMENTALS RATINGS
NVS: Fundamental Ratings
NVS
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
PROFIT vs RISK RATING
1..100
30
SMR RATING
1..100
22
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
90
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NVSOGN
RSI
ODDS (%)
Bullish Trend 4 days ago
61%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
47%
Bearish Trend 4 days ago
68%
Momentum
ODDS (%)
Bullish Trend 4 days ago
49%
Bullish Trend 4 days ago
70%
MACD
ODDS (%)
Bullish Trend 4 days ago
51%
Bullish Trend 4 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
48%
Bullish Trend 4 days ago
67%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
40%
Bullish Trend 4 days ago
63%
Advances
ODDS (%)
Bullish Trend 4 days ago
46%
Bullish Trend 10 days ago
67%
Declines
ODDS (%)
Bearish Trend 16 days ago
45%
Bearish Trend 5 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
41%
Bearish Trend 4 days ago
72%
Aroon
ODDS (%)
Bearish Trend 4 days ago
31%
Bearish Trend 4 days ago
78%
View a ticker or compare two or three
Ad is loading...
NVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY591.64-1.14
-0.19%
SPDR® S&P 500® ETF Trust
BTC.X99756.910000-747.585940
-0.74%
Bitcoin cryptocurrency
GME27.72-0.24
-0.86%
GameStop Corp
TSLA413.82-14.40
-3.36%
Tesla
AAPL228.26-9.61
-4.04%
Apple

NVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVS has been loosely correlated with SNY. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if NVS jumps, then SNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVS
1D Price
Change %
NVS100%
-1.22%
SNY - NVS
39%
Loosely correlated
+2.77%
AZN - NVS
36%
Loosely correlated
+1.87%
BIIB - NVS
31%
Poorly correlated
+0.16%
OGN - NVS
30%
Poorly correlated
+2.86%
PFE - NVS
28%
Poorly correlated
+1.03%
More

OGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGN has been loosely correlated with PFE. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if OGN jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGN
1D Price
Change %
OGN100%
+2.86%
PFE - OGN
35%
Loosely correlated
+1.03%
BIIB - OGN
34%
Loosely correlated
+0.16%
NVS - OGN
31%
Poorly correlated
-1.22%
AMRN - OGN
28%
Poorly correlated
-1.86%
JNJ - OGN
27%
Poorly correlated
+1.93%
More